Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project(aEuro)
Volume
26
Pagination
2392 - 2398
DOI
10.1093/annonc/mdv380
Journal
ANNALS OF ONCOLOGY
Issue
ISSN
0923-7534